Fig. 2From: Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trialTrial profile Allo-HSCT Allogeneic–hematopoietic stem-cell transplantation CR complete remission CRi complete remission with incomplete blood cell count recovery PR partial response NR no responseBack to article page